Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2323-2025Class II

HemosIL LMW Heparin Controls; Part Number: 0020300200

Instrumentation Laboratory Co. / initiated 2025-02-03 / Open, Classified / root cause: manufacturing process

Instrumentation Laboratory began a recall of HemosIL LMW Heparin Controls; Part Number: 0020300200 on . FDA classified it as Class II and gives the reason as "Multiple complaints indicating lower than expected quality control (QC) results and in some instances QC recovery below the lower limit of the package insert acceptance range when testing is performed with HemosIL...". As of , the recall status on record is Open, Classified, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-2323-2025
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Instrumentation Laboratory Co.
Product
HemosIL LMW Heparin Controls; Part Number: 0020300200;
Product code
KFF Assay, Heparin
Reason for recall
Multiple complaints indicating lower than expected quality control (QC) results and in some instances QC recovery below the lower limit of the package insert acceptance range when testing is performed with HemosIL Liquid Anti-Xa and HemosIL Heparin Calibrator. In some complaints, failure to pass QC resulted in patient testing delays.
Root cause tag
manufacturing process
FDA root cause
Process control
Action
On February 3, 2025, URGENT MEDICAL DEVICE CORRECTION letters were sent to customers. Requested Customer Actions Please take the following actions: " Follow the instructions in the original Urgent Medical Device Correction letter to update the ACL TOP test parameters with the corrected value assignments for HemosIL Heparin Calibrators (Part No. 0020300600). " For HemosIL UF Heparin Controls (Part No. 0020300300), continue to use the current target values and acceptance ranges as labeled. " For HemosIL LMW Heparin Controls (Part No. 0020300200), use the reassigned target values and acceptance ranges for the Low and High Controls as provided in the table above. " Note: if the 2D Barcode is scanned, customers need to manually override the uploaded values with those provided in this letter. " Follow the instructions below to update the Quality Control Material Definitions with the updated values (same instructions for all Instrument models): " Select Setup from the menu bar and then select Material List from the dropdown menu. " From Material List , double click on the Material Name LMW Hep Low Control and LMW Hep High Control (performed separately) to open Material Definition . " From Material Definition LMW Hep Low Control or LMW Hep High Control , click on Assigned Values icon (picture of bullseye) under the header. An editable table titled Assigned Values for IL Material Definition Quality Control LMW Hep Low Control or LMW Hep High Control will appear with the Anti-Xa Test Code, Active Lot, and Alternative Lot (if applicable). " In the Assigned Values table, select the Active and/or Alternative lot, and change the target values for LMW Hep Low Control and LMW Hep High Control to the reassigned values provided in the table. " After entering the reassigned values for LMW Hep Low Control and LMW Hep High Control , click on OK to save the changes. " Run quality controls per labeled instructions for use. New acceptance ranges for HemosIL L
Quantity in commerce
41,824 units
Distribution
Worldwide - US Nationwide and the countries of Algeria, Andorra, Argentina, Australia, Austria, Belarus, Brazil, Brunei, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Czech Republic, Denmark, Finland, Germany, Gibraltar, Greece, Guatemala, Hong Kong, Hungary, India, Ireland, Israel, Italy, Japan, Korea, Kuwait, Kyrgyzstan, Lebanon, Lithuania, Macao, Malaysia, Mexico, Panama, Paraguay, Peru, Poland, Portugal, Qatar, Romania, Russia, Saudi Arabia, Serbia, South Africa, Spain, Sweden, Switzerland, Thailand, Tunisia, Turkey, United Kingdom, Uruguay, Vietnam.
Product codes and lots
Part Number: 0020300200; UDI-DI: 08426950472490; Lot Numbers: N0330228, N0632773, N0935135, N1036592, N0148986, N0441476, N0643673, N0845161, N1147397;

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2323-2025
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2323-2025Class IIOngoingVoluntary: Firm initiated